SCHEMBL8515211

SCHEMBL8515211

CCC(=C(C(=O)O)C(=O)O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.52
CES2 O00748 2/20 0.52
ESR1 P03372 7/20 0.50
ESR2 Q92731 4/20 0.50
CYP19A1 P11511 2/20 0.50
PGR P06401 2/20 0.47
PTGS2 P35354 2/20 0.47
MAPT P10636 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ATM Q13315 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
CYP3A4 P08684 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288699 0.88 CES2 (0.46) CES1CES2ESR1ESR2CYP19A1
SCHEMBL9232542 0.84 CES1 (0.44) CES1CES2ESR1ESR2CYP19A1
SCHEMBL15673208 0.83 CES2 (0.55) CES1CES2ESR1ESR2PTGS2
SCHEMBL9447847 0.83 CES1 (0.52) CES1CES2ESR1ESR2CYP19A1
SCHEMBL8624493 0.82 ESR1 (0.60) CES1CES2ESR1ESR2CYP19A1
SCHEMBL3314631 0.81 ESR1 (0.61) CES1CES2ESR1ESR2CYP19A1
SCHEMBL8596721 0.81 ESR1 (0.61) CES1CES2ESR1ESR2CYP19A1
SCHEMBL1982010 0.81 CES2 (0.50) CES1CES2ESR1ESR2CYP19A1
SCHEMBL4613506 0.81 CES2 (0.50) CES1CES2ESR1ESR2CYP19A1
SCHEMBL5279624 0.81 CES2 (0.50) CES1CES2ESR1ESR2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642972-A1 USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS DSM IP Assets B.V. (NL) 2013-10-02 EP claimed
WO-2012069363-A1 USE OF UV-FILTERS TO STABILIZE RESVERATROL IN TOPICAL COSMETIC COMPOSITIONS DSM IP ASSETS B.V. (NL) 2012-05-31 WO claimed
US-12303468-B2 Compositions comprising one or more (bio)-alkanediols with antioxidants SYMRISE AG (DE) 2025-05-20 US disclosed
EP-4545065-A2 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS Symrise AG (DE) 2025-04-30 EP disclosed
EP-3645625-B1 HIGH STIFFNESS POLYPROPYLENE IMPACT COPOLYMER EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-03-27 EP disclosed
CN-117529377-A Organic binder, composition for producing inorganic material molded body, green body, degreased body, inorganic material molded body, and method for producing inorganic material molded body 株式会社吴羽 2024-02-06 CN disclosed
US-20230293408-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants SYMRISE AG (DE) 2023-09-21 US disclosed
US-20230293403-A1 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols SYMRISE AG (DE) 2023-09-21 US disclosed
US-20230293410-A1 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols SYMRISE AG (DE) 2023-09-21 US disclosed
US-20230293409-A1 Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection SYMRISE AG (DE) 2023-09-21 US disclosed
EP-4110477-A1 COMPOSITIONS COMPRISING ONE OR MORE (BIO)-ALKANEDIOLS WITH ANTIOXIDANTS Symrise AG (DE) 2023-01-04 EP disclosed
CN-104640887-B The manufacture method of manufacture method for the ingredient of solid catalyst of olefin polymerization, the catalyst for olefin polymerization and olefin polymerization 东邦钛株式会社 2017-08-29 CN disclosed
EP-2963063-B1 PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, CATALYST FOR POLYMERIZING OLEFINS, AND PRODUCTION METHOD FOR POLYMERIZED OLEFINS TOHO TITANIUM CO LTD (JP) 2017-06-14 EP disclosed
US-9587050-B2 Production method for solid catalyst component for polymerizing olefins, catalyst for polymerizing olefins, and production method for polymerized olefins TOHO TITANIUM CO., LTD. (JP) 2017-03-07 US disclosed
EP-2963065-A1 PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, CATALYST FOR POLYMERIZING OLEFINS, AND PRODUCTION METHOD FOR POLYMERIZED OLEFINS TOHO TITANIUM CO., LTD. (JP) 2016-01-06 EP disclosed
EP-2963063-A1 PRODUCTION METHOD FOR SOLID CATALYST COMPONENT FOR POLYMERIZING OLEFINS, CATALYST FOR POLYMERIZING OLEFINS, AND PRODUCTION METHOD FOR POLYMERIZED OLEFINS TOHO TITANIUM CO., LTD. (JP) 2016-01-06 EP disclosed
US-9206265-B2 Solid catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer TOHO TITANIUM CO., LTD. (JP) 2015-12-08 US disclosed
EP-2876118-A1 METHOD FOR PRODUCING SOLID CATALYST COMPONENT FOR USE IN POLYMERIZATION OF OLEFIN, CATALYST FOR USE IN POLYMERIZATION OF OLEFIN, AND METHOD FOR PRODUCING OLEFIN POLYMER Toho Titanium CO., LTD. (JP) 2015-05-27 EP disclosed
US-20140221583-A1 SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER TOHO TITANIUM CO., LTD. (JP) 2014-08-07 US disclosed
EP-2730590-A1 SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST FOR OLEFIN POLYMERIZATION, AND METHOD FOR PRODUCING OLEFIN POLYMER Toho Titanium CO., LTD. (JP) 2014-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230293408-A1 Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants MMP8, CXCL8, IL18 CES1 1474/4885CES2 1308/4885ESR1 3131/4885
US-20230293403-A1 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols CUTA, TRPA1, SMURF2 CES1 1191/4885CES2 566/4885ESR1 898/4885
US-12303468-B2 Compositions comprising one or more (bio)-alkanediols with antioxidants MMP8, CXCL8, IL18 CES1 1474/4885CES2 1308/4885ESR1 3131/4885
US-20230293410-A1 Compositions Comprising Lipophilic Compounds and One or More (Bio)-Alkanediols TRPA1, CUTA, OR51E2 CES1 1369/4885CES2 739/4885ESR1 1124/4885
US-20230293409-A1 Compositions Comprising Antimicrobials and (Bio)-Alkanediols for Skin Protection POLR1C, EBP, PIK3C3 CES1 1048/4885CES2 514/4885ESR1 2625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.